0001968940-23-000001.txt : 20230526 0001968940-23-000001.hdr.sgml : 20230526 20230526070032 ACCESSION NUMBER: 0001968940-23-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230526 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 23963013 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ocumension Therapeutics CENTRAL INDEX KEY: 0001840315 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: 56F, ONE MUSEUM PLACE STREET 2: 669 XIN ZHA ROAD CITY: JING'AN DISTRICT, SHANGHAI STATE: F4 ZIP: 200041 BUSINESS PHONE: 862122893688 MAIL ADDRESS: STREET 1: 56F, ONE MUSEUM PLACE STREET 2: 669 XIN ZHA ROAD CITY: JING'AN DISTRICT, SHANGHAI STATE: F4 ZIP: 200041 FORMER COMPANY: FORMER CONFORMED NAME: OcuMension Therapeutics DATE OF NAME CHANGE: 20210113 144 1 primary_doc.xml 144 0001840315 XXXXXXXX LIVE 0001314102 EYEPOINT PHARMACEUTICALS, INC. 000-51122 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 6179265000 Ocumension Therapeutics Director Common Stock Tiger Brokers (Singappre) Pte. Ltd.

1 Raffles Place, #35-61, One Raffles Place Tower 2 Singapore U0 048616

3010722 17853581.46 34301926 05/26/2023 NASDAQ Common Stock 12/31/2020 through a private placement from the issuer of the securities EYEPOINT PHARMACEUTICALS, INC. N 3010722 12/31/2020 good funds Y 05/26/2023 YE LIU